Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:liver tumor incidence/prevalence measurement
go back to main search page
Accession:CMO:0001593 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display liver tumors at a point in time or develop liver tumors within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A liver tumor is a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive occurring in and composed of cells specific to the liver, the large, dark-red organ located in the cranial portion of the abdomen of vertebrates, just behind or below the diaphragm, the functions of which include storage and filtration of blood; secretion of bile; detoxification of noxious substances; conversion of sugars into glycogen; synthesis and breakdown of fats and temporary storage of fatty acids; and synthesis of serum proteins.
Synonyms:exact_synonym: hepatic tumor incidence/prevalence measurement



show annotations for term's descendants           Sort by:

Term paths to the root